Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANNURADHA BHANDARI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1568777092
CMS profile
806580
Location
RICHMOND, IN

General Payments · PY2018–2024

$2,428.41

  • Reported across 164 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$234.00

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $234.00 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $63.13 4
ABBVIE INC. $47.16 3
Novo Nordisk AS $45.07 3
Inari Medical, Inc. $22.60 1
Daiichi Sankyo Inc. $22.34 1
Lilly USA, LLC $18.09 1
DEXCOM, INC. $15.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $209.89 14
PY2019 $198.93 18
PY2020 $472.25 31
PY2021 $398.57 28
PY2022 $427.19 28
PY2023 $487.58 31
PY2024 $234.00 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.50 02/09/2024 Food and Beverage Undisputed 01/23/2026 1103320244 CMS
ABBVIE INC. $15.65 04/26/2024 Food and Beverage Undisputed 01/23/2026 1103320246 CMS
ABBVIE INC. $14.01 06/26/2024 Food and Beverage Undisputed 01/23/2026 1103320248 CMS
AstraZeneca Pharmaceuticals LP $14.31 03/14/2024 Food and Beverage Undisputed 01/23/2026 1104577040 CMS
AstraZeneca Pharmaceuticals LP $16.65 03/20/2024 Food and Beverage Undisputed 01/23/2026 1105365187 CMS
AstraZeneca Pharmaceuticals LP $14.94 11/06/2024 Food and Beverage Undisputed 01/23/2026 1105542239 CMS
AstraZeneca Pharmaceuticals LP $17.23 11/17/2024 Food and Beverage Undisputed 01/23/2026 1105803799 CMS
Daiichi Sankyo Inc. $22.34 07/09/2024 Food and Beverage Undisputed 01/23/2026 1089400057 CMS
Dexcom, Inc. $15.61 05/13/2024 Food and Beverage Undisputed 01/23/2026 1153281657 CMS
Inari Medical, Inc. $22.60 06/12/2024 Food and Beverage Undisputed 01/23/2026 1140062906 CMS
Lilly USA, LLC $18.09 08/05/2024 Food and Beverage Undisputed 01/23/2026 1136058664 CMS
Novo Nordisk Inc $13.15 02/13/2024 Food and Beverage Undisputed 01/23/2026 1096838083 CMS
Novo Nordisk Inc $15.89 03/11/2024 Food and Beverage Undisputed 01/23/2026 1096625601 CMS
Novo Nordisk Inc $16.03 05/09/2024 Food and Beverage Undisputed 01/23/2026 1096731820 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.